Pediatrix (NYSE: MD) director McEachin reports 22,854-share stock gift

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Pediatrix Medical Group director Thomas McEachin reported charitable-style transfers of company stock. On May 13, 2026, he made bona fide gifts totaling 22,854 shares of Pediatrix common stock. One 11,427-share gift involved a trust where he and his spouse serve as trustees and beneficiaries, and another 11,427-share gift involved directly held shares.

After these transactions, McEachin reports indirect ownership of 66,073 shares through the trust and continued direct ownership of 7,196 shares. These are non-cash, gift transfers rather than open-market sales or purchases, and do not change his role as a director.

Insider Trade Summary

22,854 shares gifted

Mixed 2 txns

Insider McEachin Thomas

Role null

Type	Security	Shares	Price	Value
Gift	Common Stock	11,427	$0.00	--
Gift	Common Stock	11,427	$0.00	--

Holdings After Transaction: Common Stock — 7,196 shares (Direct, null); Common Stock — 66,073 shares (Indirect, Thomas A. McEachin Living Trust dated April 17, 2025)

Footnotes (1)

On May 13, 2026, the reporting person transferred 11,427 shares of common stock to a trust of which the reporting person and his spouse are trustees and beneficiaries. The reporting person and his spouse are trustees and beneficiaries of the trust that holds the reported securities.

Key Figures

Total shares gifted: 22,854 shares Individual gift size: 11,427 shares Indirect shares after transaction: 66,073 shares +1 more

4 metrics

Total shares gifted 22,854 shares Gifted Pediatrix common stock on May 13, 2026

Individual gift size 11,427 shares Each of two bona fide gifts of common stock

Indirect shares after transaction 66,073 shares Held via Thomas A. McEachin Living Trust after gifts

Direct shares after transaction 7,196 shares Direct Pediatrix holdings following reported gifts

Key Terms

bona fide gift, indirect ownership, Form 4, trustees and beneficiaries

4 terms

bona fide gift financial

"Each transaction is coded as a bona fide gift of common stock."

A bona fide gift is a genuine, voluntary transfer of money, property, or benefits from one party to another made without expectation of repayment, services, or hidden conditions. Investors care because such gifts can affect company disclosures, related‑party transaction rules, tax treatment, and perceived conflicts of interest; think of it like someone giving you a present with no strings attached — but on a corporate scale, auditors and regulators need to verify it really is unconditional.

indirect ownership financial

"Indirect ownership is reported through the Thomas A. McEachin Living Trust."

Form 4 regulatory

"The Form 4 discloses McEachin’s gift transfers of Pediatrix shares."

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

trustees and beneficiaries financial

"The reporting person and his spouse are trustees and beneficiaries of the trust."

Form 4 Insider Transactions: What Each Field Means →

05/14/2026 - 05:00 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

McEachin Thomas

(Last)

(First)

(Middle)

1301 CONCORD TERRACE

(Street)

SUNRISE

FLORIDA

33323

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Pediatrix Medical Group, Inc. [ MD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/13/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	05/13/2026		G		11,427⁽¹⁾	D	$0	7,196	D
Common Stock	05/13/2026		G	V	11,427⁽¹⁾	A	$0	66,073	I	Thomas A. McEachin Living Trust dated April 17, 2025⁽²⁾

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. On May 13, 2026, the reporting person transferred 11,427 shares of common stock to a trust of which the reporting person and his spouse are trustees and beneficiaries.

2. The reporting person and his spouse are trustees and beneficiaries of the trust that holds the reported securities.

	/s/ Mary Ann E. Moore, Attorney-in-Fact	05/14/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did Pediatrix (MD) director Thomas McEachin report in this Form 4?

Director Thomas McEachin reported two bona fide gifts of Pediatrix common stock. The filing shows non-cash transfers totaling 22,854 shares, split into two 11,427-share gifts, rather than any open-market buying or selling activity.

How many Pediatrix (MD) shares did Thomas McEachin gift and on what date?

Thomas McEachin gifted a total of 22,854 Pediatrix common shares. The Form 4 shows two bona fide gifts of 11,427 shares each, both dated May 13, 2026, classified as non-derivative transactions in common stock.

How many Pediatrix (MD) shares does Thomas McEachin hold after these gifts?

After the gifts, Thomas McEachin reports indirect ownership of 66,073 Pediatrix shares through a trust and direct ownership of 7,196 shares. These post-transaction balances appear in the Form 4’s “shares following transaction” fields for the indirect and direct holdings.

Were Thomas McEachin’s Pediatrix (MD) transactions open-market sales?

No, the transactions were not open-market sales. The Form 4 classifies both as Code G bona fide gifts, with a reported price per share of 0.0000, indicating non-cash transfers rather than sales into the market.

What is the role of the trust in Thomas McEachin’s Pediatrix (MD) holdings?

A trust holds part of McEachin’s Pediatrix shares. The filing states that he and his spouse are trustees and beneficiaries of this trust, which holds the reported indirect securities, and received 11,427 shares in a transfer on May 13, 2026.

How many Pediatrix (MD) gift transactions did the Form 4 disclose?

The Form 4 disclosed two gift transactions. The transaction summary shows a gift count of 2 and total gift shares of 22,854, corresponding to the two 11,427-share bona fide gifts of Pediatrix common stock reported on May 13, 2026.